JP2022533182A5 - - Google Patents

Info

Publication number
JP2022533182A5
JP2022533182A5 JP2021568650A JP2021568650A JP2022533182A5 JP 2022533182 A5 JP2022533182 A5 JP 2022533182A5 JP 2021568650 A JP2021568650 A JP 2021568650A JP 2021568650 A JP2021568650 A JP 2021568650A JP 2022533182 A5 JP2022533182 A5 JP 2022533182A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
ripk3
composition according
inflammatory
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021568650A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022533182A (ja
JP7546603B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/032784 external-priority patent/WO2020232190A1/en
Publication of JP2022533182A publication Critical patent/JP2022533182A/ja
Publication of JP2022533182A5 publication Critical patent/JP2022533182A5/ja
Priority to JP2024145040A priority Critical patent/JP2024170457A/ja
Application granted granted Critical
Publication of JP7546603B2 publication Critical patent/JP7546603B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021568650A 2019-05-16 2020-05-14 タンパク質キナーゼ阻害剤ならびに疾患および状態の治療のためのその使用 Active JP7546603B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024145040A JP2024170457A (ja) 2019-05-16 2024-08-27 タンパク質キナーゼ阻害剤ならびに疾患および状態の治療のためのその使用

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962848648P 2019-05-16 2019-05-16
US201962848719P 2019-05-16 2019-05-16
US62/848,719 2019-05-16
US62/848,648 2019-05-16
PCT/US2020/032784 WO2020232190A1 (en) 2019-05-16 2020-05-14 Protein kinase inhibitors and uses thereof for the treatment of diseases and conditions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024145040A Division JP2024170457A (ja) 2019-05-16 2024-08-27 タンパク質キナーゼ阻害剤ならびに疾患および状態の治療のためのその使用

Publications (3)

Publication Number Publication Date
JP2022533182A JP2022533182A (ja) 2022-07-21
JP2022533182A5 true JP2022533182A5 (enExample) 2023-05-02
JP7546603B2 JP7546603B2 (ja) 2024-09-06

Family

ID=70919255

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021568650A Active JP7546603B2 (ja) 2019-05-16 2020-05-14 タンパク質キナーゼ阻害剤ならびに疾患および状態の治療のためのその使用
JP2024145040A Pending JP2024170457A (ja) 2019-05-16 2024-08-27 タンパク質キナーゼ阻害剤ならびに疾患および状態の治療のためのその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024145040A Pending JP2024170457A (ja) 2019-05-16 2024-08-27 タンパク質キナーゼ阻害剤ならびに疾患および状態の治療のためのその使用

Country Status (6)

Country Link
US (1) US12516055B2 (enExample)
EP (2) EP3968991B1 (enExample)
JP (2) JP7546603B2 (enExample)
AU (1) AU2020275304B2 (enExample)
CA (1) CA3137869A1 (enExample)
WO (1) WO2020232190A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018213219A1 (en) * 2017-05-15 2018-11-22 University Of Houston System Pyrido[2,3-d]pyrimidin-7ones and related compounds as inhibitors of protein kinases
AU2020275304B2 (en) * 2019-05-16 2025-01-23 Institute For Cancer Research D/B/A The Research Institute Of Fox Chase Cancer Center Protein kinase inhibitors and uses thereof for the treatment of diseases and conditions
CN113072471B (zh) * 2021-03-02 2022-09-16 四川美大康华康药业有限公司 一种利非司特中间体及其制备方法
WO2024097805A1 (en) * 2022-11-01 2024-05-10 Trustees Of Tufts College Mixed lineage kinase domain like pseudokinase (mlkl) activators
WO2024199388A1 (zh) * 2023-03-29 2024-10-03 微境生物医药科技(上海)有限公司 作为myt1抑制剂的化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117923A (en) * 1995-05-03 2000-06-01 Warner Lambert Co Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
US6150359A (en) 1997-08-20 2000-11-21 Warner-Lambert Company Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation
JP2003523358A (ja) * 2000-01-27 2003-08-05 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 神経変性疾患の治療のためのピリドピリミジノン誘導体
WO2014031571A1 (en) * 2012-08-21 2014-02-27 Icahn School Of Medicine At Mount Sinai Treatment of viral infections
WO2015179436A1 (en) 2014-05-19 2015-11-26 Sanford-Burnham Medical Research Institute Inflammation therapy using mekk3 inhibitors or blocking peptides
WO2018213219A1 (en) 2017-05-15 2018-11-22 University Of Houston System Pyrido[2,3-d]pyrimidin-7ones and related compounds as inhibitors of protein kinases
AU2020275304B2 (en) * 2019-05-16 2025-01-23 Institute For Cancer Research D/B/A The Research Institute Of Fox Chase Cancer Center Protein kinase inhibitors and uses thereof for the treatment of diseases and conditions

Similar Documents

Publication Publication Date Title
JP2022533182A5 (enExample)
CN111094242B (zh) 用于治疗与nlrp活性相关的病症的化合物和组合物
JP2022529370A5 (enExample)
KR102224081B1 (ko) 치환된 피롤리진 화합물 및 그의 용도
EP3331863B1 (en) Novel compounds as ror gamma modulators
JP2013515074A5 (enExample)
CN113365998A (zh) 用于parp抑制剂的吲哚并七元酰肟类似物
CN114072396A (zh) 作为dna-pk抑制剂的喹啉和噌啉衍生物
WO2014181287A1 (en) Heterocyclyl compounds and uses thereof
CN112533916A (zh) 一种作用于crbn蛋白的三并环类化合物
CN114555569A (zh) Nlrp3调节剂
PH12019550083A1 (en) Inhibitors of bruton's tyrosine kinase
WO2019130230A1 (en) Heterocyclic amides as kinase inhibitors
JP2000505451A (ja) キノロン類およびこれらの治療的使用
JP2019507114A5 (enExample)
US20160175316A1 (en) Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection
BR112020005279A2 (pt) compostos de 4-[[(7-aminopirazolo[1,5-a]pirimidin-5-il)amino]metil]piperidin-3-ol como inibidores cdk
JP2000505450A (ja) キノロン類およびこれらの治療的使用
JP2024170457A5 (enExample)
EP3068387A1 (en) Compounds and methods for the treatment of malaria
JP2019529460A5 (enExample)
CN104650070A (zh) 二氢嘧啶类化合物及其在药物中的应用
CN110612286A (zh) 氰基取代的稠合双环衍生物及其制备方法和用途
JP7005508B2 (ja) ヒトライノウイルスの阻害剤としてのアルキニルヌクレオシド類似体
CA3205023A1 (en) Pyrido[2,3-d]imidazole derivatives and their use as inhibitors of itk for the teatment of skin disease